ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome

Cell

Volumn 117, Issue 3, 2004, Pages 387-398

  Yang, Xiangli ^a   Matsuda, Koichi ^a   Bialek, Peter ^a   Jacquot, Sylvie ^b   Masuoka, Howard C ^c   Schinke, Thorsten ^a   Li, Lingzhen ^a   Brancorsini, Stefano ^b   Sassone Corsi, Paolo ^b   Townes, Tim M ^c   Hanauer, Andre ^b   Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; COLLAGEN TYPE 1; PROTEIN SERINE THREONINE KINASE; RIBOSOMAL SERINE THREONINE KINASE 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MATRIX; CELL DIFFERENTIATION; CELL FUNCTION; COFFIN LOWRY SYNDROME; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERINATAL PERIOD; PRIORITY JOURNAL; RIBOSOME;

ANIMALIA;

EID: 11144357428     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(04)00344-7     Document Type: Article

References (43)

1. nd ed. (San Diego: Academic Press).
2. Bonadio J., Holbrook K.A., Gelinas R.E., Jacob J., Byers P.H. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J. Biol. Chem. 260:1985;1734-1742
3. Bruning J.C., Gillette J.A., Zhao Y., Bjorbaeck C., Kotzka J., Knebel B., Avci H., Hanstein B., Lingohr P., Moller D.E., et al. Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc. Natl. Acad. Sci. USA. 97:2000;2462-2467
4. Coffin R., Phillips J.L., Staples W.I., Spector S. Treatment of lead encephalopathy in children. J. Pediatr. 69:1966;198-206
5. Dalby K.N., Morrice N., Caudwell F.B., Avruch J., Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273:1998;1496-1505
6. De Cesare D., Jacquot S., Hanauer A., Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factorinduced phosphorylation of CREB protein and transcription of c-fos gene. Proc. Natl. Acad. Sci. USA. 95:1998;12202-12207
7. Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M., Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 25:2000;406-409
8. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1995;1858-1869
9. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1. a transcriptional activator of osteoblast differentiation Cell. 89:1997;747-754
10. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1999;1025-1036
11. Dufresne S.D., Bjorbaek C., El-Haschimi K., Zhao Y., Aschenbach W.G., Moller D.E., Goodyear L.J. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21:2001;81-87
12. Fisher T.L., Blenis J. Evidence for two catalytically active kinase domains in pp90rsk. Mol. Cell. Biol. 16:1996;1212-1219
13. Frodin M., Jensen C.J., Merienne K., Gammeltoft S. A phosphoserine- regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J. 19:2000;2924-2934
14. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development. Cell. 107:2001;513-523
15. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell. 5:2000;897-904
16. Harding H.P., Zeng H., Zhang Y., Jungries R., Chung P., Plesken H., Sabatini D.D., Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. Mol. Cell. 7:2001;1153-1163
17. Harding H.P., Calfon M., Urano F., Novoa I., Ron D. Transcriptional and translational control in the Mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18:2002;575-599
18. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell. 11:2003;619-633
19. Hettmann T., Barton K., Leiden J.M. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev. Biol. 222:2000;110-123
20. Joel P.B., Smith J., Sturgill T.W., Fisher T.L., Blenis J., Lannigan D.A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1998;1978-1984
21. Johnson R.S., Spiegelman B.M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577-586
22. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:2002;389-406
23. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A. 2nd, Hartmann C., Li L., Hwang T.H., Brayton C.F., et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157:2002;303-314
24. Kwok C., Weller P.A., Guioli S., Foster J.W., Mansour S., Zuffardi O., Punnett H.H., Dominguez-Steglich M.A., Brook J.D., Young I.D., et al. Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. Am. J. Hum. Genet. 57:1995;1028-1036
25. Lee B., Thirunavukkarasu K., Zhou L., Pastore L., Baldini A., Hecht J., Geoffroy V., Ducy P., Karsenty G. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16:1997;307-310
26. Lowry B., Miller J.R., Fraser F.C. A new dominant gene mental retardation syndrome. Association with small stature, tapering fingers, characteristic facies, and possible hydrocephalus. Am. J. Dis. Child. 121:1971;496-500
27. Masuoka H.C., Townes T.M. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood. 99:2002;736-745
28. McKnight S.L. CCAAT/Enhancer Binding Protein, Vol. 2. 1992;Cold Spring Harbor Laboratory Press, New York
29. McLeod M.J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology. 22:1980;299-301
30. Merienne K., Jacquot S., Zeniou M., Pannetier S., Sassone-Corsi P., Hanauer A. Activation of RSK by UV-light. phosphorylation dynamics and involvement of the MAPK pathway Oncogene. 19:2000;4221-4229
31. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773-779
32. Parfitt A.M., Simon L.S., Villanueva A.R., Krane S.M. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase. J. Bone Miner. Res. 2:1987;427-436
33. Poteet-Smith C.E., Smith J.A., Lannigan D.A., Freed T.A., Sturgill T.W. Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogen-activated protein kinase-activated protein kinase family. J. Biol. Chem. 274:1999;22135-22138
34. Prockop D.J., Kivirikko K.I. Collagens. molecular biology, diseases, and potentials for therapy Annu. Rev. Biochem. 64:1995;403-434
35. Schinke T., Karsenty G. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters. J. Biol. Chem. 274:1999;30182-30189
36. Sims N.A., Dupont S., Krust A., Clement-Lacroix P., Minet D., Resche-Rigon M., Gaillard-Kelly M., Baron R. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 30:2002;18-25
37. Tanaka T., Tsujimura T., Takeda K., Sugihara A., Maekawa A., Terada N., Yoshida N., Akira S. Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres. Genes Cells. 3:1998;801-810
38. Temtamy S.A., Miller J.D., Hussels-Maumenee I. The Coffin-Lowry syndrome. an inherited faciodigital mental retardation syndrome J. Pediatr. 86:1975;724-731
39. Trivier E., De Cesare D., Jacquot S., Pannetier S., Zackai E., Young I., Mandel J.L., Sassone-Corsi P., Hanauer A. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature. 384:1996;567-570
40. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and hematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745
41. Xing J., Ginty D.D., Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273:1996;959-963
42. Young I.D. The Coffin-Lowry syndrome. J. Med. Genet. 25:1988;344-348
43. Zhang P., McGrath B., Li S., Frank A., Zambito F., Reinert J., Gannon M., Ma K., McNaughton K., Cavener D.R. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol. Cell. Biol. 22:2002;3864-3874